Aculife Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Aculife Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $10.6M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aculife Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $10.6M Trade | TransData Nexus

Aculife Healthcare Private Limited

Indian Pharmaceutical Exporter · Advanced Antibiotics Specialist · $10.6M Total Trade · DGFT Verified

Aculife Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $10.6M across 6 products in 4 therapeutic categories. Based on 347 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Heparin ($4.4M), Metronidazole ($3.0M), Linezolid ($1.5M).

Aculife Healthcare Private Limited — Export Portfolio & Destination Treemap

Aculife Healthcare Private Limited pharmaceutical export portfolio — 6 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Aculife Healthcare Private Limited? — Company Overview & Market Position

Aculife Healthcare Private Limited, established on July 28, 2014, is a private pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U24233GJ2014PTC080271. As of March 31, 2025, Aculife reported an authorized capital of ₹600.00 crore and a paid-up capital of ₹431.48 crore. The company employs approximately 2,880 professionals, reflecting its significant presence in the pharmaceutical manufacturing sector.

Aculife specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its product portfolio spans six products across four therapeutic categories, with a notable concentration in advanced antibiotics and cardiovascular medications. The company's registered office is located at Commerce House - V, Besides Vodafone House, Prahladnagar Corporate Road, Ahmedabad, Gujarat, 380051, India.

What Does Aculife Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Heparin$4.4M 2

Product Portfolio — Top 6 by Export Value

Aculife Healthcare Private Limited exports 6 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Heparin	Cardiovascular	$4.4M	88	1.2%	9
2	Metronidazole	Advanced Antibiotics	$3.0M	140	1.5%	9
3	Linezolid	Advanced Antibiotics	$1.5M	42	3.9%	8
4	Piperacillin	Advanced Antibiotics	$867.2K	18	1.0%	10
5	Levofloxacin	Antibiotics	$722.7K	45	1.0%	15
6	Metoclopramide	Gastrointestinal	$167.1K	14	0.7%	13

Aculife Healthcare Private Limited exports 6 pharmaceutical products across 4 therapeutic categories with a total export value of $10.6M. The top category is Advanced Antibiotics (50.2% of portfolio), followed by Cardiovascular (41.4%), indicating a concentrated portfolio with the top 5 products accounting for 98.4% of total export value.

Aculife Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Aculife Healthcare operates manufacturing facilities in Ahmedabad, Gujarat, India. While specific details regarding plant locations and capacities are not publicly disclosed, the company's substantial workforce and product portfolio suggest well-equipped facilities capable of producing a diverse range of pharmaceutical formulations. The focus on advanced antibiotics and cardiovascular products indicates specialized manufacturing capabilities in these therapeutic areas.

3Key Leadership

The leadership team at Aculife Healthcare includes:

Guhaprasad Nagarajan: Chief Executive Officer (CEO), appointed on November 29, 2023.

Amar Narendrabhai Shah: Whole-Time Director, serving since May 23, 2017.

Ajay Bhushanlal Khushu: Director, with tenure since July 28, 2014.

Paresh Balmukund Sheth: Director, also serving since July 28, 2014.

These leaders bring extensive experience to the company, guiding its strategic direction and operational execution.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Aculife Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Aculife Healthcare's export activities, as reported by TransData Nexus, include shipments to various international markets. However, specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly available. The company's focus on advanced antibiotics and cardiovascular products suggests potential interest in these regulated markets, where such therapeutics are in demand. Further information would require direct engagement with regulatory bodies or the company itself.

2Emerging Markets

Aculife Healthcare's export data indicates shipments to emerging markets, including regions in Africa, Latin America, and Southeast Asia. The company's product portfolio, particularly in advanced antibiotics and cardiovascular medications, aligns with the healthcare needs in these regions. While specific details on WHO prequalification or other certifications enabling access to these markets are not publicly disclosed, the company's export activities suggest a strategic focus on expanding its presence in emerging markets.

3Geographic Strategy

Aculife Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Aculife Healthcare's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data suggests a focus on markets where such regulatory approvals are essential. For comprehensive information, direct engagement with the FDA or the company is recommended.

2WHO & EU GMP

Information regarding Aculife Healthcare's WHO prequalification, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status is not publicly disclosed. Given the company's export activities, obtaining these certifications would be advantageous for accessing international markets. Prospective partners should verify the company's compliance with these standards through direct communication.

3CDSCO & Indian Regulatory

Aculife Healthcare holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has approvals from state drug controllers, as indicated by its active status and compliance with Indian regulatory requirements. The company's export activities suggest it possesses the necessary export No Objection Certificates (NOCs) for international shipments. For detailed verification, consulting the CDSCO or the company directly is advisable.

Aculife Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Aculife Healthcare operates in the competitive pharmaceutical manufacturing sector, focusing on advanced antibiotics and cardiovascular products. While specific competitors are not identified in the available data, the company's product portfolio positions it in direct competition with other manufacturers specializing in these therapeutic areas. Market share comparisons and head-to-head analyses would require access to detailed industry reports and competitor data.

2Key Differentiators

Aculife Healthcare's focus on high-demand therapeutic areas, such as advanced antibiotics and cardiovascular medications, distinguishes it in the pharmaceutical manufacturing sector. The company's substantial export activities and product portfolio reflect its commitment to addressing global healthcare needs. Further insights into its unique strengths and competitive advantages would require direct engagement with the company.

3Strategic Position

Aculife Healthcare's strategic direction appears to emphasize the production of high-demand pharmaceutical formulations, particularly in advanced antibiotics and cardiovascular products. The company's export activities suggest a focus on expanding its presence in both regulated and emerging markets. Future outlooks would depend on market dynamics, regulatory developments, and the company's ability to adapt to evolving healthcare needs.

Buyer Due Diligence Brief — Evaluating Aculife Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Aculife Healthcare's substantial export volume and product portfolio indicate a reliable track record in pharmaceutical manufacturing. The company's focus on high-demand therapeutic areas suggests consistency in meeting market needs. Reliability indicators, such as on-time delivery and product quality, would require direct feedback from customers and partners.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Facility Registration: Confirm the company's registration status with the FDA.

WHO-GMP Certification: Verify compliance with World Health Organization Good Manufacturing Practices.

EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Aculife Healthcare Private Limited

How many pharmaceutical products does Aculife Healthcare Private Limited export from India?

Aculife Healthcare Private Limited exports 6 pharmaceutical products across 4 therapeutic categories. The top exports are Heparin ($4.4M), Metronidazole ($3.0M), Linezolid ($1.5M), Piperacillin ($867.2K), Levofloxacin ($722.7K). Total export value is $10.6M.

What is Aculife Healthcare Private Limited's total pharmaceutical export value?

Aculife Healthcare Private Limited's total pharmaceutical export value is $10.6M, based on 347 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Aculife Healthcare Private Limited cover?

Aculife Healthcare Private Limited exports across 4 therapeutic categories. The largest are Advanced Antibiotics (50.2%, 3 products), Cardiovascular (41.4%, 1 products), Antibiotics (6.8%, 1 products).

Get Full Aculife Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.